|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2002-7-25
|
|
pubmed:abstractText |
Hydralazine and isosorbide dinitrate combination (H+ISDN), angiotensin-converting enzyme inhibitors, and beta-blockers have improved outcomes in heart failure (HF). Analysis of previous trials has shown that H+ISDN appears especially beneficial in African American patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1071-9164
|
|
pubmed:author |
pubmed-author:A-HeFT Investigators,
pubmed-author:CohnJay NJN,
pubmed-author:FerdinandKeithK,
pubmed-author:FranciosaJoseph AJA,
pubmed-author:LoscalzoJosephJ,
pubmed-author:OfiliElizabethE,
pubmed-author:OlukotunAdeoyeA,
pubmed-author:TaylorAnne LAL,
pubmed-author:WorcelManuelM,
pubmed-author:YancyClyde WCW,
pubmed-author:ZiescheSusanS
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
8
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
128-35
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12140804-Adolescent,
pubmed-meshheading:12140804-Adult,
pubmed-meshheading:12140804-African Continental Ancestry Group,
pubmed-meshheading:12140804-Aged,
pubmed-meshheading:12140804-Double-Blind Method,
pubmed-meshheading:12140804-Drug Combinations,
pubmed-meshheading:12140804-Female,
pubmed-meshheading:12140804-Heart Failure,
pubmed-meshheading:12140804-Humans,
pubmed-meshheading:12140804-Hydralazine,
pubmed-meshheading:12140804-Informed Consent,
pubmed-meshheading:12140804-Isosorbide Dinitrate,
pubmed-meshheading:12140804-Male,
pubmed-meshheading:12140804-Middle Aged,
pubmed-meshheading:12140804-Patient Selection,
pubmed-meshheading:12140804-Research Design,
pubmed-meshheading:12140804-Treatment Outcome,
pubmed-meshheading:12140804-Vasodilator Agents,
pubmed-meshheading:12140804-Ventricular Dysfunction, Left
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
African-American Heart Failure Trial (A-HeFT): rationale, design, and methodology.
|
|
pubmed:affiliation |
Zena and Michael A. Wiener Cardiovascular Institute, Mt. Sinai School of Medicine, New York, New York, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
